HMGN.US Hemagen Diagnostics Inc

Healthcare Health Care Equipment & Supplies USA Stocks
0.0002 USD
Close of Jul 9, 2026
0.0001 0.0026
Market cap
USD 3.10K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Sep 2012.

Is HMGN.US undervalued?

Graham number

The Graham number of Hemagen Diagnostics Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Hemagen Diagnostics Inc fundamental analysis

No fundamental analysis for Hemagen Diagnostics Inc yet.

Hemagen Diagnostics Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Hemagen Diagnostics Inc

Hemagen Diagnostics, Inc. provides human and veterinary diagnostic services worldwide. The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins. Its proprietary test kits are used to aid in the diagnosis of certain autoimmune and infectious diseases. It also provides human diagnostics, such as universal IFA components; supplies, controls and calibr…

Full company profile